Literature DB >> 29769855

Why has the Ebola outbreak in West Africa been so challenging to control?

T Semalulu1, G Wong2, G Kobinger2, P Huston3.   

Abstract

West Africa is in the midst of the largest Ebola outbreak ever; there have been over 1000 deaths and many new cases are reported each day. The World Health Organization (WHO) declared it an outbreak in March 2014 and on August 6, 2014 the WHO declared the outbreak a public health emergency of international concern. Based on the number of deaths and total number of cases reported to the WHO as of August 11, 2014, the current outbreak has an overall mortality rate of 55%. Outbreak control measures against Ebola virus disease are effective. Why then, has this outbreak been so challenging to control? Ebola is transmitted through bodily fluids and immediately attacks the immune system, then progressively attacks the major organs and the lining of blood vessels. Sierra Leone, Guinea and Liberia are small countries that have limited resources to respond to prolonged outbreaks, especially in rural areas. This has been made more challenging by the fact that health care workers are at risk of contracting Ebola virus disease. Treatment to date has been supportive, not curative and outbreak control strategies have been met with distrust due to fear and misinformation. However, important progress is being made. The international response to Ebola is gaining momentum, communication strategies have been developed to address the fear and mistrust, and promising treatments are under development, including a combination of three monoclonal antibodies that has been administered to two American Ebola infected health care workers. The National Microbiology Laboratory of the Public Health Agency of Canada (PHAC) has been supporting laboratory diagnostic efforts in West Africa and PHAC has been working with the provinces and territories and key stakeholders to ensure Canada is prepared for a potential Ebola importation.

Entities:  

Year:  2014        PMID: 29769855      PMCID: PMC5864427          DOI: 10.14745/ccdr.v40i14a01

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  29 in total

Review 1.  Ebola virus pathogenesis: implications for vaccines and therapies.

Authors:  Nancy Sullivan; Zhi-Yong Yang; Gary J Nabel
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

2.  An analysis of features of pathogenesis in two animal models of Ebola virus infection.

Authors:  E I Ryabchikova; L V Kolesnikova; S V Luchko
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

3.  Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection.

Authors:  Elias A Said; Franck P Dupuy; Lydie Trautmann; Yuwei Zhang; Yu Shi; Mohamed El-Far; Brenna J Hill; Alessandra Noto; Petronela Ancuta; Yoav Peretz; Simone G Fonseca; Julien Van Grevenynghe; Mohamed R Boulassel; Julie Bruneau; Naglaa H Shoukry; Jean-Pierre Routy; Daniel C Douek; Elias K Haddad; Rafick-Pierre Sekaly
Journal:  Nat Med       Date:  2010-03-07       Impact factor: 53.440

4.  Emergence of Zaire Ebola virus disease in Guinea.

Authors:  Sylvain Baize; Delphine Pannetier; Lisa Oestereich; Toni Rieger; Lamine Koivogui; N'Faly Magassouba; Barrè Soropogui; Mamadou Saliou Sow; Sakoba Keïta; Hilde De Clerck; Amanda Tiffany; Gemma Dominguez; Mathieu Loua; Alexis Traoré; Moussa Kolié; Emmanuel Roland Malano; Emmanuel Heleze; Anne Bocquin; Stephane Mély; Hervé Raoul; Valérie Caro; Dániel Cadar; Martin Gabriel; Meike Pahlmann; Dennis Tappe; Jonas Schmidt-Chanasit; Benido Impouma; Abdoul Karim Diallo; Pierre Formenty; Michel Van Herp; Stephan Günther
Journal:  N Engl J Med       Date:  2014-04-16       Impact factor: 91.245

5.  Fruit bats as reservoirs of Ebola virus.

Authors:  Eric M Leroy; Brice Kumulungui; Xavier Pourrut; Pierre Rouquet; Alexandre Hassanin; Philippe Yaba; André Délicat; Janusz T Paweska; Jean-Paul Gonzalez; Robert Swanepoel
Journal:  Nature       Date:  2005-12-01       Impact factor: 49.962

6.  Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis.

Authors:  Nadia Wauquier; Pierre Becquart; Cindy Padilla; Sylvain Baize; Eric M Leroy
Journal:  PLoS Negl Trop Dis       Date:  2010-10-05

7.  Multiple Ebola virus transmission events and rapid decline of central African wildlife.

Authors:  Eric M Leroy; Pierre Rouquet; Pierre Formenty; Sandrine Souquière; Annelisa Kilbourne; Jean-Marc Froment; Magdalena Bermejo; Sheilag Smit; William Karesh; Robert Swanepoel; Sherif R Zaki; Pierre E Rollin
Journal:  Science       Date:  2004-01-16       Impact factor: 47.728

Review 8.  Review of Ebola virus infections in domestic animals.

Authors:  H M Weingartl; C Nfon; G Kobinger
Journal:  Dev Biol (Basel)       Date:  2013-05-14

9.  Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb.

Authors:  Xiangguo Qiu; Jonathan Audet; Gary Wong; Lisa Fernando; Alexander Bello; Stéphane Pillet; Judie B Alimonti; Gary P Kobinger
Journal:  Sci Rep       Date:  2013-11-28       Impact factor: 4.379

Review 10.  Immunopathology of highly virulent pathogens: insights from Ebola virus.

Authors:  Carisa A Zampieri; Nancy J Sullivan; Gary J Nabel
Journal:  Nat Immunol       Date:  2007-11       Impact factor: 25.606

View more
  1 in total

1.  Local perspectives on Ebola during its tenth outbreak in DR Congo: A nationwide qualitative study.

Authors:  Basilua Andre Muzembo; Ngangu Patrick Ntontolo; Nlandu Roger Ngatu; Januka Khatiwada; Kabamba Leon Ngombe; Oscar Luboya Numbi; Kabamba Michel Nzaji; Kabinda Jeff Maotela; Mukonkole Jean Ngoyi; Tomoko Suzuki; Koji Wada; Shunya Ikeda
Journal:  PLoS One       Date:  2020-10-22       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.